Research Paper On Cystic Fibrosis

Discovered in 1989, Cystic Fibrosis is the most common, fatal genetic disease in the United States. Statistics show that 30,000 people in the US have been named with this disease. (Genome) Cystic Fibrosis is a disease caused when the CFTR (Cystic Fibrosis Transmembrane Regulator) is defective and the cells do not release the right amount of chloride. This causes for the body to produce thick, sticky mucus that clogs up the lungs, leads to infection, blocks the pancreas, which stops the digestive enzymes from reaching the intestine. Symptoms require; salty tasting skin, wheezing, shortness of breath, persistent coughing, poor growth or weight gain, frequent/bulky stool, and male infertility. 1000 new cases are diagnosed each year, 75% of those

Some suffer more with their digestive system than their lungs so it is a different routine for different people. Even with the life expectancy, different people in different ages have a different time or length of years to live. It depends on how the treatment hits you and how CF affects your body, because this disease can affect everyone differently. So the life expectancy is probably at 41 years old, but for babies that are born now a days are expected to be able to live longer. Cystic Fibrosis on a daily bases would be like having a complete job 24/7 to keep yourself alive. There is daily treatments regime including physiotherapy, oral, nebulized, and occasionally antibiotics, and taking enzyme tablets with food. Some people may even have a feeding tube overnight. For those who are very ill, daily routines can be hard for them, it would just leave them breathless. Some patients of Cystic Fibrosis even use wheelchairs to get around and use oxygen to

It is used to improve Cystic Fibrosis care and treatment, and it aims to ensure that there is appropriate clinical care and help support the patients with CF. Ever since they began in 1964 we have funded research into every aspect of cystic fibrosis. Together with their national and international partners they continued to increase the understanding of Cystic Fibrosis and improve understanding, treatments and management of cystic fibrosis. They are also involved with social research, exploring the non-medical impact of Cystic Fibrosis, and its implications for quality and length of life. They also received a grant of 1 Million dollars to use for funding of CF